Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2015 Sep 1;8(9):9752–9759.

Duodenal gangliocytic paraganglioma: report of two cases and review of literature

Bo Wang 1, Yinying Zou 1, Han Zhang 1, Liming Xu 1, Xiaojun Jiang 1, Ke Sun 1
PMCID: PMC4637770  PMID: 26617685

Abstract

We report two cases of Gangliocytic paraganglioma (GP), one of which was accompanied by lymph node metastasis. Histologically, the tumor was composed of three morphologically distinct cell populations: spindle cells, ganglion-like cells and epithelioid cells. The epithelioid cells were positive for cytokeratin (AE1/AE3), synaptophysin (Syn), chromogranin A (CgA), CD56 and progesterone receptor (PR). Ganglion-like cell types showed positive reactivity for Syn and CD56. In contrast, the spindle-shaped cells showed positive reactivity for S-100. The patient with lymph node metastasis has a good prognosis. Nonetheless, close surveillance is still necessary for patients with GP because a few cases of GP with regional lymph node metastasis and even distant metastasis have been published, including a malignant case of GP showing a lethal course.

Keywords: Gangliocytic paraganglioma, synaptophysin, chromogranin A, CD117

Introduction

Gangliocytic paraganglioma (GP) is a rare tumor that is mainly located in the second portion of the duodenum [1,2]. It accounts for 6% to 9% of duodenal gastrointestinal neuroendocrine tumors (NETs), ranking the third most frequent histopathologic type after gastrinomas and somatostatinomas [3]. It is featured by its triphasic cellular differentiation, composed of eptihelioid neuroendocrine cells, spindle-shaped cells with Schwannian cell differentiation and ganglion-like cells [1]. According to the World Health Organization (WHO) classification, this tumor has generally been regarded as benign, but a few cases with regional lymph node metastasis and even distant metastasis have been reported. To date, 23 cases of GP with lymph node metastasis and 3 cases with distant metastasis have been published (Table 1). Herein we presented two cases of GP, one of which was accompanied by lymph node metastasis (case 1).

Table 1.

Clinicalpathological findings of gangliocytic paraganglioma with lymph node or distant metastasis

No. Reference Age (yr)/gender Tumor site Tumor size (mm) Lymph node metastasis Distant metastasis Treatment Follow up (months)
1 Buchler et al [4] 50/male Ampulla of Vater 30 Yes No LR NED 20 mo
2 Korbi et al [5] 73/female Duodenum NA Yes No WP NA
3 Inai et al [6] 17/male Duodenum 20 Yes No WP NED 32 mo
4 Hashimoto et al [7] 47/male Second portion of the duodenum 65 Yes No WP NED 14 mo
5 Dookhan et al [8] 41/male Duodenum 25 Yes No LR+WP Recurrence 11 years after first LR
6 Takabayashi et al [9] 63/female Papilla of Vater 32 Yes No WP NED 24 mo
7 Tomic et al [10] 74/female Pancreas 40 Yes No WP NED 19 mo
8 Henry et al [11] 50/male Pancreas 25 Yes Bone WP NA
9 Sundararajan et al [12] 67/female Second portion of the duodenum 50 Yes No WP NED 9 mo
10 Bucher et al [13] 31/female Papilla of Vater 30 Yes No WP NED 44 mo
11 Wong et al [14] 49/female Duodenum 14 Yes No WP+RT NED 12 mo
12 Witkiewicz et al [15] 38/female Papilla of Vater 15 Yes No LR+WP NA
13 Mann et al [16] 17/female Duodenum NA Yes No WP NED 12 mo
14 Okubo et al [1] 61/male Papilla of Vater 30 Yes No WP NED 6 mo
15 Saito et al [17] 28/male Papilla of Vater NA Yes No WP NA
16 Sandmann et al [18] 62/female Ampulla of Vater 50 Yes No LR NA
17 Uchida et al [19] 67/female Second portion of the duodenum NA Yes No WP NA
18 Rowsell et al [20] 52/female Duodenum 10 Yes Liver LR NED 27 mo
19 Ogata et al [21] 16/male Ampulla of Vater 25 Yes No WP NED 36 mo
20 Barret et al [22] 51/female Duodenal papilla 35 Yes No WP NED 8 yr
21 Bin Li et al [23] 47/male Duodenal papilla 30 Yes Liver and pelvic cavity WP+RT+CT+pelvic mass resection Die 13 mo after initial surgery
22 Huijuan Shi et al [24] 47/male Ampulla of Vater 40 Yes No WP NED 24 mo
23 Okubo et al [25] 74/female Second portion of the duodenum 23 Yes No WP NED 6 mo

LR: Local resection; WP: Whipple procedure; CT: chemotherapy; RT: Radiotherapy; NA: Not available; NED: No evidence of disease.

Case report

Case 1

A 42-year-old man presented with melana and dizziness for 3 weeks. He was admitted to a local hospital. He denied abdominal pain, nausea, vomiting and fever. His laboratory data revealed anemia (blood hemoglobin value 56 g/L). Computed tomographic (CT) scans showed a mass in the third portion of the duodenum. It was suspected as a leiomyoma. For further examination and treatment he was then transferred to our hospital. CT scans also revealed a mass with 31 mm×24 mm in the third portion of the duodenum. Endoscopic ultrasonography showed a polypoid tumor in duodenum and ulceration on the surface of the lesion. The patient underwent local surgical excision on 7/22/2010. Unfortunately, the follow-up of the patient is not established.

Case 2

A 49-year-old man was admitted to our institute with upper abdominal pain for nine days. He denied nausea, vomiting and changes in bowel habits. Laboratory results were within normal range. CT scans revealed a mass with 38 mm×25 mm near the head of pancreas (Figure 1), involving the second portion of the duodenum. Enlarged peripancreatic lymph nodes were observed. Endoscopic ultrasonography detected a lesion with 33 mm×18 mm near the head of pancreas, involving the second portion of the duodenum. The surface of the tumor was smooth without bleeding or ulceration. The patient underwent pancreaticoduodenectomy and lymph node dissection on 2/13/2012. Subsequently, the patient received chemotherapy for 5 cycles.

Figure 1.

Figure 1

The image of CT in case 2. CT scans revealed a mass between the head of pancreas and the duodenum papilla (red arrow).

To date, the patient remains well and no recurrence has been recognized in a three-year follow-up period.

Pathological findings

Grossly, a mass measuring 30mm in the largest dimension was found in the resected specimen of case 1. It was covered by the mucosa. Ulceration was found on the surface. The surgical specimen of case 2 consisted of the duodenum, bile duct, gallbladder and head of the pancreas. A solid tumor 40×30×30 mm in size was located between the head of pancreas and the duodenum papilla. The mucosa was smooth without bleeding or ulceration. A total of nine lymph nodes were also removed.

Microscopically, the tumor in case 1 was localized in submucosal layer, showing an expansive growth pattern (Figure 2). The lesion focally invaded the peri-tissue. Ulceration was observed on the surface of the mucosa. The tumor in case 2 involved the whole wall of the duodenum (Figure 3), encroaching on the pancreas (Figure 4). The microscopical characteristics of the two cases were similar. The tumor was composed of three morphologically distinct cell populations: spindle cells, ganglion-like cells and epithelioid cells. The epithelial cells arranged in the nests and trabeculae, with round to oval-shaped nucleus and pale eosinophilic cytoplasm. The spindle cells, with an elongated nucleus and attenuated eosinophilic cytoplasm, formed slender fascicles encompassing the nests of epithelioid cells (Figure 5). Ganglion-like cells were rarely seen and had a round nucleus with conspicuous nucleolus (Figure 6). There was no mitotic figure or necrosis in the foci. Moreover, in case 2, the tumor cells focally mixed with the proliferative bile ducts (Figure 7).

Figure 2.

Figure 2

The tumor in case 1. The tumor showed an expansive growth pattern (HE staining with original magnification ×50).

Figure 3.

Figure 3

The tumor in case 2. The tumor involved the whole wall of the duodenum (HE staining with original magnification ×100).

Figure 4.

Figure 4

The tumor encroached the nearby pancreas (HE staining with original magnifcation ×100).

Figure 5.

Figure 5

HE staining of the tumor. The tumor was composed of three morphologically distinct cell populations: spindle cells, ganglion-like cells and epithelioid cells (HE staining with original magnifcation ×400).

Figure 6.

Figure 6

HE staining of Ganglion-like cells. These cells were rarely seen and had a round nucleus with conspicuous nucleolus (HE staining with original magnifcation ×400).

Figure 7.

Figure 7

HE staining of case 2. The tumor cells in case 2 focally mixed with the proliferative bile ducts (HE staining with original magnification ×100).

The metastatic tumor was found in three of nine lymph nodes in case 2. The histological features in the metastases were identical with the primary lesion (Figure 8).

Figure 8.

Figure 8

HE staining of the lymph node. The metastatic tumor was found in the lymph node (HE staining with original magnifcation ×100).

Immunohistochemical findings

Immunohistochemically, the epithelioid cells were positive for cytokeratin (AE1/AE3), synaptophysin (Syn), chromogranin A (CgA), CD56 and progesterone receptor (PR). Ganglion-like cell types showed positive reactivity for Syn and CD56. In contrast, the spindle-shaped cells showed positive reactivity for S-100. The expression of Ki-67 was extremely low (Figure 9). Bcl-2 and P53 showed negative reactivity. In addition, in case 2, numerous cells positive for CD117 scattered in the stroma (Figure 10), which indicated they were mast cells. Inversely, these cells were relatively scarce in case 1 (Figure 11). The expression pattern of these biomarkers in the metastatic tumor in lymph nodes was similar with that in the primary lesion.

Figure 9.

Figure 9

Immunohistochemical analysis of the tumors in the duodenum. The epithelioid cells were positive for CK (A), Syn (B), CgA (C), CD56 (D) and PR (E). Ganglion-like cells showed positive reactivity for Syn (F). The spindle-shaped cells showed positive reactivity for S-100 (G). The expression of Ki-67 was extremely low (H). (A-H: Immunohistochemical staining with original magnification ×400).

Figure 10.

Figure 10

Immunohistochemical staining of CD117 in case 2. Numerous cells positive for CD117 scattered in the stroma (Immunohistochemical staining with original magnification ×400).

Figure 11.

Figure 11

Immunohistochemical staining of CD117 in case 1. The cells positive for CD117 were scarce. (Immunohistochemical staining with original magnification ×400).

Discussion

GP consists of three types of cells: spindle cells, ganglion-like cells and epithelioid cells [1]. Identification of the three components is essential for the diagnosis of GP. The tumor cells always arrange in solid and trabecular pattern, mainly comprising spindle cells, mixed with nests of epithelioid cells and large cells with gangliocytic differentiation [24]. Besides, other unusual structures have been reported. Huijun et al reported a case of GP with distinct glandular component embedded in the spindle tumor cells in the primary tumor and the metastatic lymph nodes [24]. Moreover, Ogata et al also found a small glandular component with mucus was present in the primary tumor and more prevalent in the lymph node metastasis [21].

GP should be distinguished from carcinoid tumor, ganglioneuroma, pigmented paraganglioma and spindle cell tumors as gastrointestinal stromal tumor (GIST) [26-28]. Immunohistochemical examination has been regarded as an important diagnostic clue for GP. In epithelial cells and ganglion-like cells, CD56 and Syn showed the highest positive rates. For the identification of the spindle-shaped cells, S-100 protein would be the candidate with no doubt [25]. Moreover, Yoichiro et al demonstrated that the epithelial cells showed significantly higher positive reactivity for PR and pancreatic polypeptide (PP) than duodenal carcinoid tumor [25]. Naturally, PR and PP were also employed to make differential diagnoses of GP from carcinoid tumor. In the present two cases, the epithelial cells showed positive reactivity for PR, which was consistent with the published data.

GP was firstly described by Dahl et al in 1957 [29]. Since then about 200 cases of GP have been reported. Generally, it is regarded as a benign lesion. With the more cases of GP with regional lymph node metastasis and even distant metastasis published, the biological behavior of GP should be redefined, especially after a malignant GP of the duodenum showing a lethal course was reported by Bin et al [23]. Researchers have tried to find out some biomarkers served as prognostic indicators but failed. Bcl-2, P53 and Ki-67 were acceptable prognostic factors in several kinds of neuroendocrine tumors. However, bcl-2 and P53 showed negative reactivity in all cases of GP [1,30]. Moreover, no matter whether lymph nodes metastases were present, Ki-67 labeling index was extremely low, even in the lethal case (less than 1% in both primary and metastatic foci) [23,25,30]. Similarly, we also demonstrated that the tumor cells showed negative reactivity for bcl-2 and P53 not only in the primary lesion, but also in the metastatic foci. Ki-67 positive staining was rarely present. Therefore, these biomarkers may have limited value in predicting the outcome of GP. In addition, histological features, such as necrosis or mitoses, were hardly seen in the lesion. Some authors suggested other important factors involved in the malignant process of GP and molecular techniques needed to interpret the underlying mechanisms.

Mast cells are immune cells that accumulate in the tumors and their microenviroment during disease progression. They express high levels of the tyrosine kinase receptor Kit (CD117) [31]. In vitro studies have shown that mast cells have the potential to influence many aspects of tumor biology, including tumor development, tumor-induced angiogenesis, and tissue remodeling, and the shaping of adaptive immune responses to tumors [32]. However, the contribution of mast cells to the tumor biology in vivo is still under investigation. In our two cases, we found that the presence of mast cells was more frequently in case 2 than that in case 1. We have no idea whether this is occasional owing to the limited number of cases. More cases should be recruited to elucidate the intrinsic association.

In this article, we report two cases of GP, one of which was accompanied by lymph node metastasis. The patient with lymph node metastasis has a good prognosis. Because of the metastases, close surveillance is still necessary. A long time follow-up is needed to know exactly the prognosis.

Acknowledgements

This study was conducted with the approval of the Ethics Committee of The First Affiliated Hospital, College of Medicine, Zhejiang University.

Disclosure of conflict of interest

None.

References

  • 1.Okubo Y, Yokose T, Tuchiya M, Mituda A, Wakayama M, Hasegawa C, Sasai D, Nemoto T, Shibuya K. Duodenal gangliocytic paraganglioma showing lymph node metastasis: a rare case report. Diagn Pathol. 2010;5:27. doi: 10.1186/1746-1596-5-27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schethauer BW, Nora FE, Lechago J, Wick MR, Crawford BG, Weiland LH, Carney JA. Duodenal gangliocytic paraganglioma; clinicalpathological and immunohistochemical study of 11 cases. Am J Clin Pathol. 1986;86:559–565. doi: 10.1093/ajcp/86.5.559. [DOI] [PubMed] [Google Scholar]
  • 3.Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005;19:675–697. doi: 10.1016/j.bpg.2005.05.009. [DOI] [PubMed] [Google Scholar]
  • 4.Buchler M, Malfertheiner P, Baczako K, Krautzberger W, Beger HG. A metastatic endocrine-neurogenic tumor of the ampulla of Vater multiple endocrine immunoreaction-malignant paraganglioma? Digestion. 1985;31:54–59. doi: 10.1159/000199178. [DOI] [PubMed] [Google Scholar]
  • 5.Korbi S, Kapanci Y, Widgren S. Malignant paraganglioma of the duodenum: Immunohistochemical and ultrastructural study of a case. Ann Pathol. 1987;7:47–55. [PubMed] [Google Scholar]
  • 6.Inai K, Kobuke T, Yonehara S, Tokuoka S. Duodenal gangliocytic paraganglioma with lymph node metastasis in a 17-year-old boy. Cancer. 1989;63:2540–2545. doi: 10.1002/1097-0142(19890615)63:12<2540::aid-cncr2820631231>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  • 7.Hashimoto S, Kawasaki S, Matsuzawa K, Harada H, Makuuchi M. Gangliocytic paraganglioma of the papilla of Vater with regional lymph node metastasis. Am J Gastroenterol. 1992;87:1216–1218. [PubMed] [Google Scholar]
  • 8.Dookhan DB, Miettinen M, Finkel G, Gibas Z. Recurrent duodenal gangliocytic paraganglioma with lymph node metastasis. Histopathology. 1993;22:399–401. doi: 10.1111/j.1365-2559.1993.tb00145.x. [DOI] [PubMed] [Google Scholar]
  • 9.Takabayashi N, Kimura T, Yoshida M, Sakuramachi S, Harada Y, Kino I. A case report of duodenal gangliocytic paraganglioma with lymph node metastasis. Jpn Soc Gastroenterol Surg. 1993;26:2444–2448. [Google Scholar]
  • 10.Tomic S, Warner T. Pancreatic somatostatin-secreting gangliocytic paraganglioma with lymph node metastasis. Am J Gastroenterol. 1996;91:607–608. [PubMed] [Google Scholar]
  • 11.Henry C, Ghalel-Mechaoui H, Bottero N, Pradier T, Moindrot H. Gangliocytic paraganglioma of the pancreas with bone metastasis. Ann Chir. 2003;128:336–338. doi: 10.1016/s0003-3944(03)00097-x. [DOI] [PubMed] [Google Scholar]
  • 12.Sundararajan V, Robinson-Smith TM, Lowy AM. Duodenal gangliocytic paraganglioma with lymph node metastasis: a case report and review of the literature. Arch Pathol Lab Med. 2003;127:e139–e141. doi: 10.5858/2003-127-e139-DGPWLN. [DOI] [PubMed] [Google Scholar]
  • 13.Bucher P, Mathe Z, Buhler L, Chilcott M, Gervaz P, Egger JF, Morel P. Paraganglioma of the ampulla of Vater: a potentially malignant neoplasm. Scand J Gastroenterol. 2004;39:291–295. doi: 10.1080/00365520310007503. [DOI] [PubMed] [Google Scholar]
  • 14.Wong A, Miller AR, Metter J, Thomas CR. Locally advanced duodenal gangliocytic paraganglioma treated with adjuvant radiation therapy: case report and review of the literature. World J Surg Oncol. 2005;3:15. doi: 10.1186/1477-7819-3-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Witkiewicz A, Galler A, Yeo CJ, Gross SD. Gangliocytic paraganglioma: case report and review of the literature. J Gastrointest Surg. 2007;11:1351–1354. doi: 10.1007/s11605-007-0217-9. [DOI] [PubMed] [Google Scholar]
  • 16.Mann CM, Bramhall SR, Buckels JA, Taniere P. An unusual case of duodenal obstruction-gangliocytic paraganglioma. J Hepatobiliary Pancreat Surg. 2009;16:562–565. doi: 10.1007/s00534-009-0092-8. [DOI] [PubMed] [Google Scholar]
  • 17.Saito J, Hirata N, Furuzono M, Nakaji S, Inase M, Nagano H, Iwata M, Tochitani S, Fukatsu K, Fujii H, Ishii E, Kataoka J, Mikata R, Masuya Y, Ito H, Ohmori J, Wakasugi S, Ebara M, Hoshi K. A case of duodenal gangliocytic paraganglioma with lymph node metastasis. Nihon Shokakibyo Gakkai Zasshi. 2010;107:639–648. [PubMed] [Google Scholar]
  • 18.Sandmann M, Fahndrich M, Lorenzen J, Heike M. Gangliocytic paraganglioma-a rare cause of an upper gastrointestinal bleeding. Z Gastroenterol. 2010;48:1297–1300. doi: 10.1055/s-0029-1245521. [DOI] [PubMed] [Google Scholar]
  • 19.Uchida D, Ogawa T, Ueki T, Kominami Y, Numata N, Matsusita H, Morimoto Y, Nakarai A, Ota S, Nanba S, Takada S, Iwado S, Kurome M, Ohe H, Okamoto R, Uematsu S, Nakagawa M, Ishida K, Araki Y, Mizuno M. A case of gangliocytic paraganglioma with lymphoid metastasis. Nihon Shokakibyo Gakkai Zasshi. 2010;107:1456–1465. [PubMed] [Google Scholar]
  • 20.Rowsell C, Coburn N, Chetty R. Gangliocytic paraganglioma: a rare case with metastases of all 3 elements to liver and lymph nodes. Ann Diagn Pathol. 2011;15:467–471. doi: 10.1016/j.anndiagpath.2010.07.009. [DOI] [PubMed] [Google Scholar]
  • 21.Ogata S, Horio T, Sugiura Y, Aiko S, Aida S. Duodenal gangliocytic paraganglioma with regional lymph node metastasis and a glandular component. Pathol Int. 2011;61:104–107. doi: 10.1111/j.1440-1827.2010.02620.x. [DOI] [PubMed] [Google Scholar]
  • 22.Barret M, Rahmi G, Duong van Huyen JP, Landi B, Cellier C, Berger A. Duodenal gangliocytic paraganglioma with lymph node metastasis and an 8-year follow-up: a case report. Eur J Gastroenterol Hepatol. 2012;24:90–94. doi: 10.1097/MEG.0b013e32834dfdfa. [DOI] [PubMed] [Google Scholar]
  • 23.Li B, Li Y, Tian XY, Luo BN, Li Z. Malignant gangliocytic paraganglioma of the duodenum with distant metastases and a lethal course. World J Gastroenterol. 2014;20:15454–15461. doi: 10.3748/wjg.v20.i41.15454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shi HJ, Han J, Liu N, Ye ZY, Li ZX, Li Z, Peng TS. A gangliocytic partially glandular paraganglioma with lymph node metastasis. Diagn Pathol. 2014;9:63. doi: 10.1186/1746-1596-9-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yoichiro O, Tetsuo N, Megumi W, Naobumi T, Minoru S, Takao I, Kyoko A, Masuru T, Hajime A, Kanade K, Takeshi F, Takashi N, Tomoyuki Y, Yasuo O, Kazutoshi S. Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan. BMC Cancer. 2015;15:269. doi: 10.1186/s12885-015-1308-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Van ES, Offerhaus GJ, Peterse HL, Dingemans KP, Blaauwgeers HL. Gangliocytic paraganglioma of the appendix. Histopathology. 2000;36:47–49. doi: 10.1046/j.1365-2559.2000.00881.x. [DOI] [PubMed] [Google Scholar]
  • 27.Jinchen H, Jitao W, Cai L, Jiang L, Lang Z, Qu G, Liu H, Yao W, Yu G. Retroperitoneal composite pheochromocytoma-ganglioneuroma: a case report and review of literature. Diagn Pathol. 2013;8:63–67. doi: 10.1186/1746-1596-8-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhao L, Luo J, Zhang H, Da J. Pigmented paraganglioma of the kidney: a case report. Diagn Pathol. 2012;7:77–81. doi: 10.1186/1746-1596-7-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Dahl EV, Waugh JM, Dahlin DC. Gastrointestinal ganglioneuromas: brief review with report of a duodenal ganglioneuroma. Am J Pathol. 1957;33:953–965. [PMC free article] [PubMed] [Google Scholar]
  • 30.Okubo Y, Wakayama M, Nemoto T, Kitahara K, Nakayama H, Shibuya K, Yokose T, Yamada M, Shimodaira K, Sasai D, Ishiwatari T, Tsuchiya M, Hiruta N. Literature survey on epidemiology and pathology of gangliocytic paraganglioma. BMC Cancer. 2011;11:187. doi: 10.1186/1471-2407-11-187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pittoni P, Piconese S, Tripodo C, Colombo MP. Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene. 2011;30:757–769. doi: 10.1038/onc.2010.494. [DOI] [PubMed] [Google Scholar]
  • 32.Thomas M, Mindy T, Stephen JG. Mast cells: Potential positive and negative roles in tumor biology. Cancer Immunol Res. 2013;1:269–279. doi: 10.1158/2326-6066.CIR-13-0119. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES